PFS Partners’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,863
Closed -$120K 594
2025
Q4
$120K Buy
7,863
+306
+4% +$4.55K 0.05% 110
2025
Q3
$113K Buy
7,557
+156
+2% +$2.26K 0.05% 107
2025
Q2
$106K Buy
7,401
+152
+2% +$2.12K 0.05% 105
2025
Q1
$105K Hold
7,249
0.06% 97
2024
Q4
$109K Buy
7,249
+277
+4% +$4.2K 0.06% 100
2024
Q3
$104K Buy
6,972
+140
+2% +$2.01K 0.06% 95
2024
Q2
$95.7K Buy
6,832
+132
+2% +$1.85K 0.06% 91
2024
Q1
$98.2K Hold
6,700
0.07% 91
2023
Q4
$93.8K Buy
+6,700
New +$91.3K 0.06% 92

Other funds holding DIAX

PFS Partners's DIAX Position: Q1 2026 in Review

PFS Partners sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 7,863 shares — an estimated $120K sold.

PFS Partners first reported a position in DIAX in Q4 2023 and held it in 9 quarters. The position peaked at $120K in Q4 2025. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

  • PFS Partners reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
  • PFS Partners sold 7,863 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $120K.
  • PFS Partners first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2023 and held it in 9 quarters.
  • PFS Partners's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $120K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on PFS Partners's 13F filing for Q1 2026, filed 9 Apr 2026.